Michal Hammel Selected Research

Genomic Instability

1/2020

Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michal Hammel Research Topics

Disease

13	Neoplasms (Cancer) 05/2024 - 10/2010
2	Infections 01/2023 - 10/2018
2	Atherosclerosis 07/2006 - 10/2004
1	Blister (Bulla) 01/2023
1	COVID-19 05/2022
1	Superinfection 01/2022
1	Lyme Disease (Disease, Lyme) 12/2021
1	End Stage Liver Disease 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2020
1	Genomic Instability 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 02/2012
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2006
1	Osteoporosis 10/2004

Drug/Important Bio-Agent (IBA)

6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2013
3	EnzymesIBA 01/2021 - 10/2004
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2019
2	AntibodiesIBA 01/2024 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2011
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 02/2013
1	RNA (Ribonucleic Acid)IBA 05/2024
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 05/2024
1	Polysaccharides (Glycans)IBA 01/2024
1	Immunoglobulin G (IgG)IBA 01/2024
1	Immunoglobulin A (IgA)IBA 01/2024
1	SaltsIBA 01/2023
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	mRNA VaccinesIBA 05/2022
1	Lipid NanoparticlesIBA 05/2022
1	Nucleic AcidsIBA 05/2022
1	Human Serum Albumin FDA LinkGeneric 01/2022
1	Single-Domain AntibodiesIBA 01/2022
1	ProdrugsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Complement System Proteins (Complement)IBA 12/2021
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	Peptide Hydrolases (Proteases)FDA Link 12/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	Ligases (Synthetase)IBA 11/2021
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021
1	AlbuminsIBA 01/2021
1	DNA-Activated Protein KinaseIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	BilirubinIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Long Noncoding RNAIBA 11/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	EndonucleasesIBA 01/2020
1	4-aminophenylphosphate (PNPP)IBA 10/2019
1	Protein Phosphatase 1IBA 10/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 02/2012
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2012
1	Adenosine Triphosphatases (ATPase)IBA 04/2011
1	Adenosine Triphosphate (ATP)IBA 04/2011
1	Rad51 RecombinaseIBA 10/2010
1	CholesterolIBA 07/2006
1	oxidized low density lipoproteinIBA 07/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2006
1	LipoxygenasesIBA 10/2004
1	LipidsIBA 10/2004

Therapy/Procedure

2	Therapeutics 01/2024 - 11/2020
1	Immunomodulation 01/2024
1	Traction 05/2022
1	Drug Therapy (Chemotherapy) 01/2021